Telemedicine for Patients With an Hybrid Closed Loop System
A Telemedicine Platform for Patients With Type 1 Diabetes Mellitus Treated With an Hybrid Closed Loop System
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
A NA clinical study on Diabetes Mellitus, Type 1, this trial is completed. The trial is conducted by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jul 2022 — Oct 2023 [monthly]
Recruiting NA
-
Jun 2021 — Jul 2022 [monthly]
Recruiting NA
First recorded
May 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
For direct contact, visit the study record on ClinicalTrials.gov .